Empowering Digital Diabetes Management through Four Pillars
Frontier Focus
Latest research, congress highlights, and guideline interpretations
Case Study
Clinical reasoning and practical insights through real-world cases.
Sinocare achievements
Original research and breakthroughs in digital healthcare.
Clinical Practical
Multidisciplinary application of diabetes products and services.
CGM Real-Time Feedback Guides Elderly Diabetes Treatment: From "Hyperglycemic Crisis" to "Stable Target Achievement"
A case of a 65-year-old newly diagnosed elderly type 2 diabetic woman with severe hyperglycemia, diabetic nephropathy, macrovascular lesions and dyslipidemia, who was admitted before cataract surgery. Guided by real-time CGM data, clinicians adjusted insulin pump doses and later switched to premixed insulin plus acarbose. Her average blood glucose dropped to 6.9 mmol/L and TIR rose to 91% with no obvious hypoglycemia. CGM enabled dynamic glucose tracking, precise medication adjustment and safe glycemic control, proving valuable for elderly diabetic patients with complications.
CGM Guided Precise Glycemic Control——A Case of Hypoglycemia Risk Resolution in a Diabetic Patient with End-Stage Renal Disease
A 54‑year‑old patient with type 2 diabetes complicated by multiple complications and uremia suffered from recurrent severe hypoglycemia. Guided by continuous glucose monitoring (CGM), the dose of insulin detemir was individually titrated. The patient achieved stable glycemic targets without hypoglycemia, providing a reliable strategy for precise glycemic control in patients with diabetic nephropathy.
CGM Assists in the Management of Drug-Induced Hypoglycemia: Precise Intervention from "Confusion" to "Glycemic Homeostasis"
A 71‑year‑old female was hospitalized for drug‑induced hypoglycemic coma, complicated with diabetes, hypertension and coronary heart disease. Real‑time CGM guided adjustments of glucose infusion and anti‑diabetic regimens, achieving rapid glycemic stabilization with 100% TIR upon discharge. This case validates CGM’s capacity for precise early‑warning against recurrent hypoglycemia and integrated glycemic management for high‑risk patients.
